{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The neuroscientist who leads the National Institute on Drug Abuse is facing a powerful enemy: prescription drug abuse.", "headline": {"content_kicker": "Profiles in Science", "sub": "A Merging of Missions Arming Doctors With Tools;In the first of a series, the head of the U.S. drug-abuse agency talks about addiction (including hers, to chocolate).;", "print_headline": "A General in the Drug War", "kicker": "Profiles in Science: Nora D. Volkow", "seo": "An Addiction Expert Faces a Formidable Foe: Prescription Drugs", "main": "A General in the Drug War"}, "abstract": null, "print_page": "1", "word_count": "2316", "_id": "5373547e79881023b5215dc8", "snippet": "The neuroscientist who leads the National Institute on Drug Abuse is facing a powerful enemy: prescription drug abuse.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/06/14/science/14volkow.html", "multimedia": [{"subtype": "wide", "url": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-articleLarge.jpg", "height": 343, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-articleLarge.jpg", "xlargeheight": "343"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/06/14/science/12VOLK_SPAN/12VOLK_SPAN-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Volkow, Nora D", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "National Institute on Drug Abuse", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Brain", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Dopamine", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Abigail", "lastname": "ZUGER"}], "original": "By ABIGAIL ZUGER"}, "document_type": "article", "pub_date": "2011-06-14T00:00:00Z", "section_name": "Science"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Parkinson\u2019s patients are pursuing whatever it takes to remain as healthy and functional as possible.", "headline": {"content_kicker": "Personal Health", "sub": "More Than a Movement Disorder;", "print_headline": "Marching Through Life With Parkinson\u2019s", "kicker": "Personal Health", "seo": "Patients Marching Through Lives With Parkinson\u2019s", "main": "Marching Through Life With Parkinson\u2019s"}, "abstract": null, "print_page": "7", "word_count": "1092", "_id": "540eb18879881045f3791718", "snippet": "Parkinson\u2019s patients are pursuing whatever it takes to remain as healthy and functional as possible.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/06/14/health/14brody.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/06/14/science/BROD/BROD-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/06/14/science/BROD/BROD-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Parkinson's Disease", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Brain", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Dopamine", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2011-06-14T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Dr. Karen Jaffe, an obstetrician-gynecologist in Cleveland, was only 48 when she learned she had Parkinson's disease. Four years later, she continues to maintain a full-time medical and surgical practice, even performing ritual circumcisions. ''I'm doing everything I can to stay healthy,'' she told me in an interview. ''My medications and exercises control my tremor, so doing surgery is not a problem.''", "headline": {"main": "Marching Through Life With Parkinson's", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody Personal Health column on strategies undertaken by patients suffering from Parkinson's disease to live as long and healthy a life as possible, and emerging research that is assisting them; drawing (M)", "print_page": "7", "word_count": 1098, "_id": "4fd2b8c98eb7c8105d8aee05", "snippet": "Dr. Karen Jaffe, an obstetrician-gynecologist in Cleveland, was only 48 when she learned she had Parkinson's disease. Four years later, she continues to maintain a full-time medical and surgical practice, even performing ritual circumcisions.     ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C01E6DA173EF937A25755C0A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "PARKINSON'S DISEASE"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2011-06-14T00:00:00Z", "section_name": "Health; Science"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Concerns about 3-Nitro have gotten the attention of the Food and Drug Administration.", "headline": {"seo": "Pfizer Suspends Sales of Chicken Drug", "main": "Pfizer Suspends Sales of Chicken Drug With Arsenic", "print_headline": "Pfizer Suspends Sales of Chicken Drug With Arsenic"}, "abstract": null, "print_page": "2", "word_count": "705", "_id": "540e8bf179881045f3791487", "snippet": "Concerns about 3-Nitro have gotten the attention of the Food and Drug Administration.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/06/09/business/09arsenic.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/06/09/business/Arsenic/Arsenic-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/06/09/business/Arsenic/Arsenic-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Recalls and Bans of Products", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Poultry", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Arsenic", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Agriculture", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"contributor": "William Neuman contributed reporting.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Denise", "lastname": "GRADY"}], "original": "By GARDINER HARRIS and DENISE GRADY"}, "document_type": "article", "pub_date": "2011-06-09T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Food and Drug Administration on Wednesday announced new safety restrictions on high-dose simvastatin, also known as Zocor, a cholesterol-lowering drug taken by an estimated 2.1 million Americans. The agency said the 80-milligram dose caused a potentially severe muscle disease, called myopathy, especially in the first year of taking the medication.", "headline": {"main": "F.D.A. Puts New Limits on Cholesterol Drug"}, "abstract": "Food and Drug Administration announces new safety restrictions on Merck's high-dose simvastatin, or Zocor, cholesterol-lowering drug; high doses are suspected to lead to muscle disease; photo (M)", "print_page": "2", "word_count": 522, "_id": "4fd2a1628eb7c8105d885f4c", "snippet": "The Food and Drug Administration on Wednesday announced new safety restrictions on high-dose simvastatin, also known as Zocor, a cholesterol-lowering drug taken by an estimated 2.1 million Americans.     The agency said the 80-milligram dose caused a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C01E0DB133CF93AA35755C0A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "MERCK & CO"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "ZOCOR (DRUG)"}, {"name": "subject", "value": "CHOLESTEROL"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Duff", "rank": 1, "lastname": "WILSON"}], "original": "By DUFF WILSON"}, "document_type": "article", "pub_date": "2011-06-09T00:00:00Z", "section_name": "Business; Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "The Food and Drug Administration on Wednesday announced new safety restrictions on high-dose simvastatin, also known as Zocor, a cholesterol-lowering drug taken by an estimated 2.1 million Americans.", "headline": {"main": "F.D.A. Issues Safety Alert on Zocor", "kicker": "Prescriptions"}, "abstract": "The agency conducted a lengthy study and determined that an unusually high number of people suffered from muscle injuries when taking higher dosages.", "print_page": null, "word_count": "493", "_id": "4fd3a06d8eb7c8105d8e5b60", "snippet": "The agency conducted a lengthy study and determined that an unusually high number of people suffered from muscle injuries when taking higher dosages.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2011/06/08/f-d-a-issues-safety-alert-on-zocor/", "multimedia": [], "subsection_name": "Money & Policy", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}, {"value": "Accidents and Safety", "name": "subject", "rank": "2"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject", "rank": "3"}, {"value": "Zocor (Drug)", "name": "subject", "rank": "4"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "5"}, {"value": "Merck &amp; Company Inc", "name": "organizations", "rank": "6"}, {"value": "Merck & Company Inc|MRK|NYSE", "name": "unknown", "rank": "7"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Duff", "lastname": "WILSON"}], "original": "By DUFF WILSON"}, "document_type": "blogpost", "pub_date": "2011-06-08T15:58:04Z", "section_name": "Health"}], "meta": {"hits": 6, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}